NRP1 and neoplasm: Furthermore, an in vivo study of CSC skin papillomas highlighted how anti-VEGFR2 antibodies in combination with NRP1 deletion prevented tumor metastasis and decreased tumor size through impairing CSC stemness properties (Beck et al., 2011).